Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 12-2023 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 47,628 | 39,410 | 48,513 |
| Receivables | 0 | 0 | 81,453 | 63,917 | 61,843 |
| Other current assets | 0 | 0 | 109,361 | 102,184 | 90,923 |
| TOTAL | $0 | $0 | $242,593 | $210,916 | $207,067 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 2,171,846 | 1,944,221 | 1,808,001 |
| Investments And Advances | 0 | 0 | 780,902 | 728,971 | 585,016 |
| Other Non-Current Assets | 0 | 0 | 71,001 | 71,240 | 76,521 |
| TOTAL | $N/A | $N/A | $3,023,749 | $2,744,432 | $2,469,538 |
| Total Assets | $0 | $0 | $3,266,342 | $2,955,348 | $2,676,605 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 161,748 | 116,433 | 183,878 |
| Accounts payable and accrued liabilities | 0 | 0 | 142,794 | 316,251 | 64,813 |
| Accrued Expenses | 0 | 0 | 24,223 | 31,921 | 26,569 |
| TOTAL | $0 | $0 | $338,486 | $467,043 | $278,520 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 2,097,881 | 1,706,731 | 1,642,879 |
| Deferred Revenues | N/A | N/A | 9,721 | 2,438 | 3,260 |
| Other Non-Current Liabilities | 0 | 0 | 2,430 | 2,989 | 3,467 |
| TOTAL | $N/A | $N/A | $2,127,140 | $1,732,044 | $1,671,878 |
| Total Liabilities | $0 | $0 | $2,465,626 | $2,199,087 | $1,950,398 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 17,358 | 17,358 | 17,304 |
| Common Shares | 0 | 0 | 2 | 2 | 2 |
| Retained earnings | 0 | 0 | 605,943 | 562,200 | 531,662 |
| Other shareholders' equity | 0 | 0 | 104,040 | 103,961 | 105,235 |
| TOTAL | $0 | $0 | $800,716 | $756,261 | $726,207 |
| Total Liabilities And Equity | $0 | $0 | $3,266,342 | $2,955,348 | $2,676,605 |